⌘K

Home/Filings/4/A/0001437749-23-032191

4/A//SEC Filing

Finn Jonathan 4/A

Accession 0001437749-23-032191

CIK 0001488039other

View on SEC.gov Company Profile

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 5:03 PM ET

Size

5.1 KB

Accession

0001437749-23-032191

Insider Transaction Report

Form 4/AAmended

Period: 2023-11-15

ATOSSA THERAPEUTICS, INC.ATOS

Director

Transactions

Award
Stock Option (right to buy)
2023-11-15+62,500→ 62,500 total
Exercise: $0.65Exp: 2033-11-15→ Common Stock (62,500 underlying)

Footnotes (1)

[F1]The options shall vest in four equal quarterly installments following November 15, 2023.

Documents

1 file

4
rdgdoc.xml
FORM 4/A

Issuer

ATOSSA THERAPEUTICS, INC.

CIK 0001488039

Entity typeother

Related Parties

1

filerCIK 0001981595

Filing Metadata

Form type: 4/A
Filed: Nov 14, 7:00 PM ET
Accepted: Nov 15, 5:03 PM ET
Size: 5.1 KB

View on SEC.gov